Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Syros Pharmaceuticals, Inc. (SYRS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
12/18/2019 |
GN
| GBT Secures $150 Million Non-Dilutive Term Loan Financing |
12/18/2019 |
GN
| GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia |
10/23/2018 |
GN
| Market Trends Toward New Normal in Syros Pharmaceuticals, Westlake Chemical Partners LP, SITO Mobile, ShotSpotter, Motorcar Parts of America, and Benefitfocus — Emerging Consolidated Expectations, Analyst Ratings |
05/21/2018 |
GN
| Report: Exploring Fundamental Drivers Behind Syros Pharmaceuticals, J & J Snack Foods, Wright Medical Group N.V, HCI Group, Tennant, and Ebix — New Horizons, Emerging Trends, and Upcoming Developments |
05/10/2018 |
BW
| Syros Reports First Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones |
05/03/2018 |
BW
| Syros to Report First Quarter 2018 Financial Results on Thursday, May 10, 2018 |
03/26/2018 |
GN
| Report: Developing Opportunities within AllianceBernstein Holding, Deutsche Bank Aktiengesellschaft, Syros Pharmaceuticals, Ply Gem, Ensco plc, and Berkshire Hills — Future Expectations, Projections Moving into 2018 |
03/12/2018 |
BW
| Syros Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Accomplishments and Anticipated Milestones |
03/05/2018 |
BW
| Syros to Present at Upcoming Investor Conferences |
01/24/2018 |
GN
| New Research Coverage Highlights Oracle, General Dynamics, Agile Therapeutics, Fidelity Southern, Syros Pharmaceuticals, and MSA Safety Incorporated — Consolidated Revenues, Company Growth, and Expectations for 2018 |
01/04/2018 |
BW
| Syros to Present at 36th Annual J.P. Morgan Healthcare Conference |
12/10/2017 |
BW
| Syros Announces Initial Clinical Data from Ongoing Phase 2 Trial of SY-1425 Showing Biological and Clinical Activity as Single Agent in Genomically Defined AML and MDS Patients |
11/21/2017 |
BW
| Syros to Present at 29th Annual Piper Jaffray Healthcare Conference |
11/08/2017 |
BW
| Syros Reports Third Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones |
|
|